SGLT2 Inhibition Improves Vascular Function in Patients with Type 2 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

DOI: 10.1681/asn.20233411s1853b Publication Date: 2024-05-18T03:38:16Z